BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su TP, Su TC, Nakamura Y, Tsai SY. The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems. Trends Pharmacol Sci 2016;37:262-78. [PMID: 26869505 DOI: 10.1016/j.tips.2016.01.003] [Cited by in Crossref: 154] [Cited by in F6Publishing: 151] [Article Influence: 25.7] [Reference Citation Analysis]
Number Citing Articles
1 Terada K, Migita K, Matsushima Y, Sugimoto Y, Kamei C, Matsumoto T, Mori M, Matsunaga K, Takata J, Karube Y. Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors. PLoS One 2018;13:e0209250. [PMID: 30557385 DOI: 10.1371/journal.pone.0209250] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
2 Goguadze N, Zhuravliova E, Morin D, Mikeladze D, Maurice T. Sigma-1 Receptor Agonists Induce Oxidative Stress in Mitochondria and Enhance Complex I Activity in Physiological Condition but Protect Against Pathological Oxidative Stress. Neurotox Res 2019;35:1-18. [PMID: 29127580 DOI: 10.1007/s12640-017-9838-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
3 Bravo-Caparrós I, Perazzoli G, Yeste S, Cikes D, Baeyens JM, Cobos EJ, Nieto FR. Sigma-1 Receptor Inhibition Reduces Neuropathic Pain Induced by Partial Sciatic Nerve Transection in Mice by Opioid-Dependent and -Independent Mechanisms. Front Pharmacol 2019;10:613. [PMID: 31263413 DOI: 10.3389/fphar.2019.00613] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
4 Abatematteo FS, Niso M, Contino M, Leopoldo M, Abate C. Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives. Int J Mol Sci 2021;22:6359. [PMID: 34198620 DOI: 10.3390/ijms22126359] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sasi USS, Ganapathy S, Palayyan SR, Gopal RK. Mitochondria Associated Membranes (MAMs): Emerging Drug Targets for Diabetes. Curr Med Chem 2020;27:3362-85. [PMID: 30747057 DOI: 10.2174/0929867326666190212121248] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Vigani B, Rossi S, Sandri G, Bonferoni MC, Rui M, Collina S, Fagiani F, Lanni C, Ferrari F. Dual-Functioning Scaffolds for the Treatment of Spinal Cord Injury: Alginate Nanofibers Loaded with the Sigma 1 Receptor (S1R) Agonist RC-33 in Chitosan Films. Mar Drugs 2019;18:E21. [PMID: 31887983 DOI: 10.3390/md18010021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
7 Soriani O, Rapetti-Mauss R. Sigma 1 Receptor and Ion Channel Dynamics in Cancer. Adv Exp Med Biol 2017;964:63-77. [PMID: 28315265 DOI: 10.1007/978-3-319-50174-1_6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
8 Christ MG, Huesmann H, Nagel H, Kern A, Behl C. Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo. Cells 2019;8:E211. [PMID: 30832324 DOI: 10.3390/cells8030211] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
9 Vigani B, Valentino C, Cavalloro V, Catenacci L, Sorrenti M, Sandri G, Bonferoni MC, Bozzi C, Collina S, Rossi S, Ferrari F. Gellan-Based Composite System as a Potential Tool for the Treatment of Nervous Tissue Injuries: Cross-Linked Electrospun Nanofibers Embedded in a RC-33-Loaded Freeze-Dried Matrix. Pharmaceutics 2021;13:164. [PMID: 33530643 DOI: 10.3390/pharmaceutics13020164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lenci E, Calugi L, Trabocchi A. Occurrence of Morpholine in Central Nervous System Drug Discovery. ACS Chem Neurosci 2021;12:378-90. [PMID: 33459557 DOI: 10.1021/acschemneuro.0c00729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
11 Floresta G, Amata E, Barbaraci C, Gentile D, Turnaturi R, Marrazzo A, Rescifina A. A Structure- and Ligand-Based Virtual Screening of a Database of "Small" Marine Natural Products for the Identification of "Blue" Sigma-2 Receptor Ligands. Mar Drugs 2018;16:E384. [PMID: 30322188 DOI: 10.3390/md16100384] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
12 González-Cano R, Artacho-Cordón A, Romero L, Tejada MA, Nieto FR, Merlos M, Cañizares FJ, Cendán CM, Fernández-Segura E, Baeyens JM. Urinary bladder sigma-1 receptors: A new target for cystitis treatment. Pharmacol Res 2020;155:104724. [PMID: 32105755 DOI: 10.1016/j.phrs.2020.104724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Arun AS, Eddings CR, Wilson KL. Novel missense alleles of SIGMAR1 as tools to understand emerin-dependent gene silencing in response to cocaine. Exp Biol Med (Maywood) 2019;244:1354-61. [PMID: 31324122 DOI: 10.1177/1535370219863444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Emamghoreishi M, Shahpari M, Keshavarz M. Interaction of sigma-1 receptor modulators with seizure development in pentylenetetrazole-induced kindled mice. Epilepsy Res 2019;154:74-6. [PMID: 31078073 DOI: 10.1016/j.eplepsyres.2019.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Popa R, Kamble SH, Kanumuri RS, King TI, Berthold EC, Intagliata S, Sharma A, Mccurdy CR. UPLC-MS/MS method for the quantification of MCI-77, a novel sigma-1 receptor ligand, and its application to pharmacokinetic studies. Journal of Chromatography B 2022. [DOI: 10.1016/j.jchromb.2022.123187] [Reference Citation Analysis]
16 Voronin MV, Kadnikov IA, Voronkov DN, Seredenin SB. Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease. Sci Rep 2019;9:17020. [PMID: 31745133 DOI: 10.1038/s41598-019-53413-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
17 Zhang K, Zhao Z, Lan L, Wei X, Wang L, Liu X, Yan H, Zheng J. Sigma-1 Receptor Plays a Negative Modulation on N-type Calcium Channel. Front Pharmacol 2017;8:302. [PMID: 28603497 DOI: 10.3389/fphar.2017.00302] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
18 Villemain L, Prigent S, Abou-Lovergne A, Pelletier L, Chiral M, Pontoglio M, Foufelle F, Caruso S, Pineau R, Rebouissou S, Chevet E, Zucman-Rossi J, Combettes L. Sigma 1 Receptor is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α. Cancers (Basel) 2020;12:E2213. [PMID: 32784704 DOI: 10.3390/cancers12082213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Szabo A, Kovacs A, Riba J, Djurovic S, Rajnavolgyi E, Frecska E. The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells. Front Neurosci 2016;10:423. [PMID: 27683542 DOI: 10.3389/fnins.2016.00423] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
20 Hagerman R, Hagerman P. Fragile X-associated tremor/ataxia syndrome: pathophysiology and management. Curr Opin Neurol 2021;34:541-6. [PMID: 33990099 DOI: 10.1097/WCO.0000000000000954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 He Y, Xie F, Ye J, Deuther-Conrad W, Cui B, Wang L, Lu J, Steinbach J, Brust P, Huang Y, Lu J, Jia H. 1-(4-[18F]Fluorobenzyl)-4-[(tetrahydrofuran-2-yl)methyl]piperazine: A Novel Suitable Radioligand with Low Lipophilicity for Imaging σ1 Receptors in the Brain. J Med Chem 2017;60:4161-72. [PMID: 28409931 DOI: 10.1021/acs.jmedchem.6b01723] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
22 Bao Q, Zhao M, Chen L, Wang Y, Wu S, Wu W, Liu X. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor. Life Sci 2017;175:1-10. [PMID: 28286226 DOI: 10.1016/j.lfs.2017.03.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
23 Zhemkov V, Ditlev JA, Lee WR, Wilson M, Liou J, Rosen MK, Bezprozvanny I. The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains. Elife 2021;10:e65192. [PMID: 33973848 DOI: 10.7554/eLife.65192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
24 Gueguinou M, Crottès D, Chantôme A, Rapetti-Mauss R, Potier-Cartereau M, Clarysse L, Girault A, Fourbon Y, Jézéquel P, Guérin-Charbonnel C, Fromont G, Martin P, Pellissier B, Schiappa R, Chamorey E, Mignen O, Uguen A, Borgese F, Vandier C, Soriani O. The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis. Oncogene 2017;36:3640-7. [PMID: 28114279 DOI: 10.1038/onc.2016.501] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 10.2] [Reference Citation Analysis]
25 Reyes ST, Deacon RMJ, Guo SG, Altimiras FJ, Castillo JB, van der Wildt B, Morales AP, Park JH, Klamer D, Rosenberg J, Oberman LM, Rebowe N, Sprouse J, Missling CU, McCurdy CR, Cogram P, Kaufmann WE, Chin FT. Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy. Sci Rep 2021;11:17150. [PMID: 34433831 DOI: 10.1038/s41598-021-94079-7] [Reference Citation Analysis]
26 Piechal A, Jakimiuk A, Mirowska-Guzel D. Sigma receptors and neurological disorders. Pharmacol Rep 2021. [PMID: 34350561 DOI: 10.1007/s43440-021-00310-7] [Reference Citation Analysis]
27 Skrzycki M, Kaźmierczak B. The hidden role of the Sigma1 receptor in muscle cells. J Recept Signal Transduct Res 2020;40:201-8. [PMID: 32054378 DOI: 10.1080/10799893.2020.1727924] [Reference Citation Analysis]
28 Wang J, Smith SB. A Novel Mechanism of Sigma 1 Receptor Neuroprotection: Modulation of miR-214-3p. Adv Exp Med Biol 2019;1185:463-7. [PMID: 31884655 DOI: 10.1007/978-3-030-27378-1_76] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Ortíz-Rentería M, Juárez-Contreras R, González-Ramírez R, Islas LD, Sierra-Ramírez F, Llorente I, Simon SA, Hiriart M, Rosenbaum T, Morales-Lázaro SL. TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain. Proc Natl Acad Sci U S A 2018;115:E1657-66. [PMID: 29378958 DOI: 10.1073/pnas.1715972115] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
30 Alon A, Schmidt H, Zheng S, Kruse AC. Structural Perspectives on Sigma-1 Receptor Function. Adv Exp Med Biol 2017;964:5-13. [PMID: 28315261 DOI: 10.1007/978-3-319-50174-1_2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
31 Navarro G, Medrano M, Aguinaga D, Vega-Quiroga I, Lillo A, Jiménez J, Casanovas M, Canela EI, Mallol J, Gysling K, Franco R. Differential effect of amphetamine over the corticotropin-releasing factor CRF2 receptor, the orexin OX1 receptor and the CRF2-OX1 heteroreceptor complex. Neuropharmacology 2019;152:102-11. [PMID: 30465812 DOI: 10.1016/j.neuropharm.2018.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
32 Cortesi M, Zamagni A, Pignatta S, Zanoni M, Arienti C, Rossi D, Collina S, Tesei A. Pan-Sigma Receptor Modulator RC-106 Induces Terminal Unfolded Protein Response In In Vitro Pancreatic Cancer Model. Int J Mol Sci 2020;21:E9012. [PMID: 33260926 DOI: 10.3390/ijms21239012] [Reference Citation Analysis]
33 Mavlyutov TA, Duellman T, Kim HT, Epstein ML, Leese C, Davletov BA, Yang J. Sigma-1 receptor expression in the dorsal root ganglion: Reexamination using a highly specific antibody. Neuroscience 2016;331:148-57. [PMID: 27339730 DOI: 10.1016/j.neuroscience.2016.06.030] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
34 Naia L, Ly P, Mota SI, Lopes C, Maranga C, Coelho P, Gershoni-Emek N, Ankarcrona M, Geva M, Hayden MR, Rego AC. The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models. Neurotherapeutics 2021. [PMID: 33797036 DOI: 10.1007/s13311-021-01022-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Böhm R, Bulin C, Waetzig V, Cascorbi I, Klein HJ, Herdegen T. Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections. Br J Clin Pharmacol 2021. [PMID: 33871897 DOI: 10.1111/bcp.14868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Cao X, Yao Z, Dou F, Zhang Y, Qiu Y, Zhao S, Xu X, Liu X, Liu B, Chen Y, Zhang G. Synthesis and Biological Evaluation of Sigma‐1 (σ 1 ) Receptor Ligands Based on Phenyl‐1,2,4‐oxadiazole Derivatives. C&B 2019;16:e1800599. [DOI: 10.1002/cbdv.201800599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Zhong X, Persaud L, Muharam H, Francis A, Das D, Aktas BH, Sauane M. Eukaryotic Translation Initiation Factor 4A Down-Regulation Mediates Interleukin-24-Induced Apoptosis through Inhibition of Translation. Cancers (Basel) 2018;10:E153. [PMID: 29786657 DOI: 10.3390/cancers10050153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Merlos M, Romero L, Zamanillo D, Plata-Salamán C, Vela JM. Sigma-1 Receptor and Pain. Handb Exp Pharmacol 2017;244:131-61. [PMID: 28275913 DOI: 10.1007/164_2017_9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
39 Jia H, Cai Z, Holden D, He Y, Lin SF, Li S, Baum E, Shirali A, Kapinos M, Gao H, Ropchan J, Huang Y. Positron Emission Tomography Imaging Evaluation of a Novel 18F-Labeled Sigma-1 Receptor Radioligand in Cynomolgus Monkeys. ACS Chem Neurosci 2020;11:1673-81. [PMID: 32356969 DOI: 10.1021/acschemneuro.0c00171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
40 Delprat B, Crouzier L, Su TP, Maurice T. At the Crossing of ER Stress and MAMs: A Key Role of Sigma-1 Receptor? Adv Exp Med Biol 2020;1131:699-718. [PMID: 31646531 DOI: 10.1007/978-3-030-12457-1_28] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
41 Wang M, Wan C, He T, Han C, Zhu K, Waddington JL, Zhen X. Sigma-1 receptor regulates mitophagy in dopaminergic neurons and contributes to dopaminergic protection. Neuropharmacology 2021;196:108360. [PMID: 33122030 DOI: 10.1016/j.neuropharm.2020.108360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Barwick SR, Siddiq MS, Wang J, Xiao H, Marshall B, Perry E, Smith SB. Sigma 1 Receptor Co-Localizes with NRF2 in Retinal Photoreceptor Cells. Antioxidants (Basel) 2021;10:981. [PMID: 34205384 DOI: 10.3390/antiox10060981] [Reference Citation Analysis]
43 Dorsey SG. Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy. Neurotherapeutics 2018;15:176-7. [PMID: 29110212 DOI: 10.1007/s13311-017-0584-1] [Reference Citation Analysis]
44 Atzmon A, Herrero M, Sharet-Eshed R, Gilad Y, Senderowitz H, Elroy-Stein O. Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy. Front Mol Neurosci 2018;11:336. [PMID: 30279648 DOI: 10.3389/fnmol.2018.00336] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
45 Bareli T, Ahdoot HL, Ben Moshe H, Barnea R, Warhaftig G, Gispan I, Maayan R, Rosca P, Weizman A, Yadid G. Novel Opipramol-Baclofen Combination Alleviates Depression and Craving and Facilitates Recovery From Substance Use Disorder-An Animal Model and a Human Study. Front Behav Neurosci 2021;15:788708. [PMID: 35002647 DOI: 10.3389/fnbeh.2021.788708] [Reference Citation Analysis]
46 Bareli T, Ahdoot HL, Ben-Moshe H, Barnea R, Warhaftig G, Maayan R, Roska P, Weizman A, Yadid G. Chronic opipramol treatment extinguishes cocaine craving through Rac1 in responders: A rat model study. Addict Biol 2021;26:e13014. [PMID: 33508873 DOI: 10.1111/adb.13014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Walby GD, Martin SF. Preparation of novel analogs of 2-arylpiperidines and evaluation of their sigma receptor binding affinities. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114310] [Reference Citation Analysis]
48 Omidkhoda N, Wallace Hayes A, Reiter RJ, Karimi G. The role of MicroRNAs on endoplasmic reticulum stress in myocardial ischemia and cardiac hypertrophy. Pharmacological Research 2019;150:104516. [DOI: 10.1016/j.phrs.2019.104516] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
49 Bruna J, Velasco R. Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy. Neural Regen Res 2018;13:775-8. [PMID: 29862996 DOI: 10.4103/1673-5374.232459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
50 Iwamoto M, Nakamura Y, Takemura M, Hisaoka-Nakashima K, Morioka N. TLR4-TAK1-p38 MAPK pathway and HDAC6 regulate the expression of sigma-1 receptors in rat primary cultured microglia. J Pharmacol Sci 2020;144:23-9. [PMID: 32653342 DOI: 10.1016/j.jphs.2020.06.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Pozdnyakova N, Krisanova N, Dudarenko M, Vavers E, Zvejniece L, Dambrova M, Borisova T. Inhibition of sigma-1 receptors substantially modulates GABA and glutamate transport in presynaptic nerve terminals. Experimental Neurology 2020;333:113434. [DOI: 10.1016/j.expneurol.2020.113434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
52 Abramyan AM, Yano H, Xu M, Liu L, Naing S, Fant AD, Shi L. The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor. Comput Struct Biotechnol J 2020;18:199-206. [PMID: 32055286 DOI: 10.1016/j.csbj.2019.12.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
53 Lipiński PFJ, Szűcs E, Jarończyk M, Kosson P, Benyhe S, Misicka A, Dobrowolski JC, Sadlej J. Affinity of fentanyl and its derivatives for the σ1-receptor. Medchemcomm 2019;10:1187-91. [PMID: 31391893 DOI: 10.1039/c9md00222g] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Wang J, Xiao H, Barwick S, Liu Y, Smith SB. Optimal timing for activation of sigma 1 receptor in the Pde6brd10/J (rd10) mouse model of retinitis pigmentosa. Exp Eye Res 2021;202:108397. [PMID: 33310057 DOI: 10.1016/j.exer.2020.108397] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Noyer L, Lemonnier L, Mariot P, Gkika D. Partners in Crime: Towards New Ways of Targeting Calcium Channels. Int J Mol Sci 2019;20:E6344. [PMID: 31888223 DOI: 10.3390/ijms20246344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
56 Tang SW, Leonard BE, Helmeste DM. Long COVID, neuropsychiatric disorders, psychotropics, present and future. Acta Neuropsychiatr 2022;34:109-26. [PMID: 35144718 DOI: 10.1017/neu.2022.6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Alymov AA, Kapitsa IG, Voronina TA. Neurochemical Mechanisms of Pathogenesis and Pharmacological Correction of Autism Spectrum Disorders: Current Concepts and Prospects. Neurochem J 2021;15:129-38. [DOI: 10.1134/s1819712421020033] [Reference Citation Analysis]
58 Voronin MV, Kadnikov IA, Seredenin SB. Afobazole Restores the Dopamine Level in a 6-Hydroxydopamine Model of Parkinson’s Disease. Neurochem J 2019;13:49-56. [DOI: 10.1134/s1819712419010185] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
59 Yano H, Bonifazi A, Xu M, Guthrie DA, Schneck SN, Abramyan AM, Fant AD, Hong WC, Newman AH, Shi L. Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays. Neuropharmacology 2018;133:264-75. [PMID: 29407216 DOI: 10.1016/j.neuropharm.2018.01.042] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
60 Ye T, Liu X, Qu C, Zhang C, Fo Y, Guo Y, Chen X, Shi S, Yang B. Chronic inhibition of the sigma-1 receptor exacerbates atrial fibrillation susceptibility in rats by promoting atrial remodeling. Life Sci 2019;235:116837. [PMID: 31493481 DOI: 10.1016/j.lfs.2019.116837] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
61 Toussaint M, Deuther-Conrad W, Kranz M, Fischer S, Ludwig FA, Juratli TA, Patt M, Wünsch B, Schackert G, Sabri O, Brust P. Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(-)-[18F]Fluspidine in Glioblastoma. Molecules 2020;25:E2170. [PMID: 32384802 DOI: 10.3390/molecules25092170] [Reference Citation Analysis]
62 Su TP. Non-canonical Targets Mediating the Action of Drugs of Abuse: Cocaine at the Sigma-1 Receptor as an Example. Front Neurosci 2019;13:761. [PMID: 31396041 DOI: 10.3389/fnins.2019.00761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
63 Zampieri D, Vio L, Fermeglia M, Pricl S, Wünsch B, Schepmann D, Romano M, Mamolo MG, Laurini E. Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands. European Journal of Medicinal Chemistry 2016;121:712-26. [DOI: 10.1016/j.ejmech.2016.06.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
64 Brindley RL, Bauer MB, Hartley ND, Horning KJ, Currie KPM. Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors. J Neurochem 2017;143:171-82. [PMID: 28815595 DOI: 10.1111/jnc.14149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
65 Lever JR, Fergason-cantrell EA. Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax). Pharmacological Research 2019;142:87-100. [DOI: 10.1016/j.phrs.2019.01.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
66 Weng TY, Hung DT, Su TP, Tsai SA. Loss of Sigma-1 Receptor Chaperone Promotes Astrocytosis and Enhances the Nrf2 Antioxidant Defense. Oxid Med Cell Longev 2017;2017:4582135. [PMID: 28883901 DOI: 10.1155/2017/4582135] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
67 Collina S, Bignardi E, Rui M, Rossi D, Gaggeri R, Zamagni A, Cortesi M, Tesei A. Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016). Expert Opin Ther Pat 2017;27:565-78. [PMID: 28051882 DOI: 10.1080/13543776.2017.1276569] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
68 Zhemkov V, Geva M, Hayden MR, Bezprozvanny I. Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases. Int J Mol Sci 2021;22:4082. [PMID: 33920913 DOI: 10.3390/ijms22084082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Rossino G, Rui M, Pozzetti L, Schepmann D, Wünsch B, Zampieri D, Pellavio G, Laforenza U, Rinaldi S, Colombo G, Morelli L, Linciano P, Rossi D, Collina S. Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R). Int J Mol Sci 2020;21:E7708. [PMID: 33081037 DOI: 10.3390/ijms21207708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Riad A, Zeng C, Weng CC, Winters H, Xu K, Makvandi M, Metz T, Carlin S, Mach RH. Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex. Sci Rep 2018;8:16845. [PMID: 30443021 DOI: 10.1038/s41598-018-35430-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 13.3] [Reference Citation Analysis]
71 Zhang L, Yan F, Li L, Fu H, Song D, Wu D, Wang X. New focuses on roles of communications between endoplasmic reticulum and mitochondria in identification of biomarkers and targets. Clin Transl Med 2021;11:e626. [PMID: 34841708 DOI: 10.1002/ctm2.626] [Reference Citation Analysis]
72 Niso M, Mosier PD, Marottoli R, Ferorelli S, Cassano G, Gasparre G, Leopoldo M, Berardi F, Abate C. High-affinity sigma-1 (σ1) receptor ligands based on the σ1 antagonist PB212. Future Med Chem 2019;11:2547-62. [PMID: 31633399 DOI: 10.4155/fmc-2019-0042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Mysona B, Kansara N, Zhao J, Bollinger K. The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma. Adv Exp Med Biol 2017;964:299-307. [PMID: 28315279 DOI: 10.1007/978-3-319-50174-1_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
74 Soriani O, Kourrich S. The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer. Front Neurosci 2019;13:1186. [PMID: 31780884 DOI: 10.3389/fnins.2019.01186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
75 Loiseau C, Cayetanot F, Joubert F, Perrin-Terrin AS, Cardot P, Fiamma MN, Frugiere A, Straus C, Bodineau L. Current Perspectives for the use of Gonane Progesteronergic Drugs in the Treatment of Central Hypoventilation Syndromes. Curr Neuropharmacol 2018;16:1433-54. [PMID: 28721821 DOI: 10.2174/1570159X15666170719104605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Lievens JC, Maurice T. Sigma-1 receptor: culprit and rescuer in motor neuron diseases. Neural Regen Res 2021;16:106-7. [PMID: 32788456 DOI: 10.4103/1673-5374.286961] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Jefcoate CR, Lee J. Cholesterol signaling in single cells: lessons from STAR and sm-FISH. J Mol Endocrinol 2018;60:R213-35. [PMID: 29691317 DOI: 10.1530/JME-17-0281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
78 Abatematteo FS, Mosier PD, Niso M, Brunetti L, Berardi F, Loiodice F, Contino M, Delprat B, Maurice T, Laghezza A, Abate C. Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect. Eur J Med Chem 2022;228:114038. [PMID: 34902734 DOI: 10.1016/j.ejmech.2021.114038] [Reference Citation Analysis]
79 Liu X, Fu Y, Yang H, Mavlyutov T, Li J, McCurdy CR, Guo LW, Pattnaik BR. Potential independent action of sigma receptor ligands through inhibition of the Kv2.1 channel. Oncotarget 2017;8:59345-58. [PMID: 28938641 DOI: 10.18632/oncotarget.19581] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
80 Weng TY, Tsai SA, Su TP. Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases. J Biomed Sci 2017;24:74. [PMID: 28917260 DOI: 10.1186/s12929-017-0380-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
81 Lee S, Min KT. The Interface Between ER and Mitochondria: Molecular Compositions and Functions. Mol Cells 2018;41:1000-7. [PMID: 30590907 DOI: 10.14348/molcells.2018.0438] [Cited by in F6Publishing: 44] [Reference Citation Analysis]
82 Anobile DP, Niso M, Puerta A, Fraga Rodrigues SM, Abatematteo FS, Avan A, Abate C, Riganti C, Giovannetti E. New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4. Molecules 2022;27:1682. [DOI: 10.3390/molecules27051682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Eddings CR, Arbez N, Akimov S, Geva M, Hayden MR, Ross CA. Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor. Neurobiol Dis 2019;129:118-29. [PMID: 31108174 DOI: 10.1016/j.nbd.2019.05.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
84 Shi JJ, Jia KH, Sun H, Gunosewoyo H, Yang F, Tang J, Luo J, Yu LF. Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3-Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma. ChemMedChem 2021;16:524-36. [PMID: 32964625 DOI: 10.1002/cmdc.202000461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Enkirch T, Sauber S, Anderson DE, Gan ES, Kenanov D, Maurer-Stroh S, von Messling V. Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity. Front Immunol 2019;10:1097. [PMID: 31244822 DOI: 10.3389/fimmu.2019.01097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
86 Ivy AS, Standridge SM. Rett Syndrome: A Timely Review From Recognition to Current Clinical Approaches and Clinical Study Updates. Semin Pediatr Neurol 2021;37:100881. [PMID: 33892852 DOI: 10.1016/j.spen.2021.100881] [Reference Citation Analysis]
87 Couly S, Goguadze N, Yasui Y, Kimura Y, Wang SM, Sharikadze N, Wu HE, Su TP. Knocking Out Sigma-1 Receptors Reveals Diverse Health Problems. Cell Mol Neurobiol 2020. [PMID: 33095392 DOI: 10.1007/s10571-020-00983-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
88 Mavlyutov TA, Yang H, Epstein ML, Ruoho AE, Yang J, Guo LW. APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum. Oncotarget 2017;8:51317-30. [PMID: 28881650 DOI: 10.18632/oncotarget.17906] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
89 Nakamura Y, Dryanovski DI, Kimura Y, Jackson SN, Woods AS, Yasui Y, Tsai SY, Patel S, Covey DP, Su TP, Lupica CR. Cocaine-induced endocannabinoid signaling mediated by sigma-1 receptors and extracellular vesicle secretion. Elife 2019;8:e47209. [PMID: 31596232 DOI: 10.7554/eLife.47209] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
90 Vavers E, Zvejniece L, Maurice T, Dambrova M. Allosteric Modulators of Sigma-1 Receptor: A Review. Front Pharmacol 2019;10:223. [PMID: 30941035 DOI: 10.3389/fphar.2019.00223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
91 Smith SB. Introduction to Sigma Receptors: Their Role in Disease and as Therapeutic Targets. In: Smith SB, Su T, editors. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Cham: Springer International Publishing; 2017. pp. 1-4. [DOI: 10.1007/978-3-319-50174-1_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
92 Horsager J, Fedorova TD, Berge NVD, Klinge MW, Knudsen K, Hansen AK, Alstrup AKO, Krogh K, Gormsen L, Borghammer P. Cardiac 11C-Donepezil Binding Increases With Age in Healthy Humans: Potentially Signifying Sigma-1 Receptor Upregulation. J Cardiovasc Pharmacol Ther 2019;24:365-70. [PMID: 30913922 DOI: 10.1177/1074248419838509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
93 Chen X, Zhang C, Guo Y, Liu X, Ye T, Fo Y, Qu C, Liang J, Shi S, Yang B. Chronic stimulation of the sigma-1 receptor ameliorates ventricular ionic and structural remodeling in a rodent model of depression. Life Sci 2020;257:118047. [PMID: 32629001 DOI: 10.1016/j.lfs.2020.118047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Yang H, Shen H, Li J, Stanford KI, Guo LW. Sigma-1 receptor ablation impedes adipocyte-like differentiation of mouse embryonic fibroblasts. Cell Signal 2020;75:109732. [PMID: 32750415 DOI: 10.1016/j.cellsig.2020.109732] [Reference Citation Analysis]
95 Wang SM, Wu HE, Yasui Y, Geva M, Hayden M, Maurice T, Cozzolino M, Su TP. Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine. Autophagy 2022;:1-26. [PMID: 35507432 DOI: 10.1080/15548627.2022.2063003] [Reference Citation Analysis]
96 Casanovas M, Jiménez-Rosés M, Cordomí A, Lillo A, Vega-Quiroga I, Izquierdo J, Medrano M, Gysling K, Pardo L, Navarro G, Franco R. Discovery of a macromolecular complex mediating the hunger suppressive actions of cocaine: Structural and functional properties. Addict Biol 2021;26:e13017. [PMID: 33559278 DOI: 10.1111/adb.13017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Hawner M, Ducho C. Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules. Molecules 2020;25:E5963. [PMID: 33339365 DOI: 10.3390/molecules25245963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
98 Ossa F, Schnell JR, Ortega-Roldan JL. A Review of the Human Sigma-1 Receptor Structure. Adv Exp Med Biol 2017;964:15-29. [PMID: 28315262 DOI: 10.1007/978-3-319-50174-1_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
99 Kruse A. Structural Insights into Sigma1 Function. Handb Exp Pharmacol 2017;244:13-25. [PMID: 27995388 DOI: 10.1007/164_2016_95] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
100 Wei X, Zheng Z, Feng Z, Zheng L, Tao S, Zheng B, Huang B, Zhang X, Liu J, Chen Y, Zong W, Shan Z, Fan S, Chen J, Zhao F. Sigma-1 receptor attenuates osteoclastogenesis by promoting ER-associated degradation of SERCA2. EMBO Mol Med 2022;:e15373. [PMID: 35611810 DOI: 10.15252/emmm.202115373] [Reference Citation Analysis]
101 Yi B, Sahn JJ, Ardestani PM, Evans AK, Scott LL, Chan JZ, Iyer S, Crisp A, Zuniga G, Pierce JT, Martin SF, Shamloo M. Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease. J Neurochem 2017;140:561-75. [PMID: 27926996 DOI: 10.1111/jnc.13917] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 11.2] [Reference Citation Analysis]
102 Lau DHW, Hartopp N, Welsh NJ, Mueller S, Glennon EB, Mórotz GM, Annibali A, Gomez-Suaga P, Stoica R, Paillusson S, Miller CCJ. Disruption of ER-mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis. Cell Death Dis 2018;9:327. [PMID: 29491392 DOI: 10.1038/s41419-017-0022-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
103 Borbély E, Varga V, Szögi T, Schuster I, Bozsó Z, Penke B, Fülöp L. Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ1-42-Injected, Wild-Type Mouse Model of AD. Int J Mol Sci 2022;23:2514. [PMID: 35269657 DOI: 10.3390/ijms23052514] [Reference Citation Analysis]
104 Dvorácskó S, Lázár L, Fülöp F, Palkó M, Zalán Z, Penke B, Fülöp L, Tömböly C, Bogár F. Novel High Affinity Sigma-1 Receptor Ligands from Minimal Ensemble Docking-Based Virtual Screening. Int J Mol Sci 2021;22:8112. [PMID: 34360878 DOI: 10.3390/ijms22158112] [Reference Citation Analysis]
105 Yamaguchi K, Shioda N, Yabuki Y, Zhang C, Han F, Fukunaga K. SA4503, A Potent Sigma-1 Receptor Ligand, Ameliorates Synaptic Abnormalities and Cognitive Dysfunction in a Mouse Model of ATR-X Syndrome. Int J Mol Sci 2018;19:E2811. [PMID: 30231518 DOI: 10.3390/ijms19092811] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
106 Reyes-parada M, Iturriaga-vasquez P. The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors. Expert Opinion on Drug Discovery 2016;11:969-81. [DOI: 10.1080/17460441.2016.1227317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
107 Chipot C, Dehez F, Schnell JR, Zitzmann N, Pebay-Peyroula E, Catoire LJ, Miroux B, Kunji ERS, Veglia G, Cross TA, Schanda P. Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical Studies. Chem Rev 2018;118:3559-607. [PMID: 29488756 DOI: 10.1021/acs.chemrev.7b00570] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 24.0] [Reference Citation Analysis]
108 Wang SM, Goguadze N, Kimura Y, Yasui Y, Pan B, Wang TY, Nakamura Y, Lin YT, Hogan QH, Wilson KL, Su TP, Wu HE. Genomic Action of Sigma-1 Receptor Chaperone Relates to Neuropathic Pain. Mol Neurobiol 2021;58:2523-41. [PMID: 33459966 DOI: 10.1007/s12035-020-02276-8] [Reference Citation Analysis]
109 Yano H, Liu L, Naing S, Shi L. The Effects of Terminal Tagging on Homomeric Interactions of the Sigma 1 Receptor. Front Neurosci 2019;13:1356. [PMID: 31920515 DOI: 10.3389/fnins.2019.01356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
110 Hampel H, Williams C, Etcheto A, Goodsaid F, Parmentier F, Sallantin J, Kaufmann WE, Missling CU, Afshar M. A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study. Alzheimers Dement (N Y) 2020;6:e12013. [PMID: 32318621 DOI: 10.1002/trc2.12013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
111 Kadnikov IA, Verbovaya ER, Voronkov DN, Voronin MV, Seredenin SB. Deferred Administration of Afobazole Induces Sigma1R-Dependent Restoration of Striatal Dopamine Content in a Mouse Model of Parkinson's Disease. Int J Mol Sci 2020;21:E7620. [PMID: 33076300 DOI: 10.3390/ijms21207620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
112 Voronin MV, Vakhitova YV, Seredenin SB. Chaperone Sigma1R and Antidepressant Effect. Int J Mol Sci 2020;21:E7088. [PMID: 32992988 DOI: 10.3390/ijms21197088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
113 Liu D, Yang L, Liu P, Ji X, Qi X, Wang Z, Chi T, Zou L. Sigma-1 receptor activation alleviates blood-brain barrier disruption post cerebral ischemia stroke by stimulating the GDNF-GFRα1-RET pathway. Exp Neurol 2021;:113867. [PMID: 34582837 DOI: 10.1016/j.expneurol.2021.113867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Yang K, Wang C, Sun T. The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson's Disease (PD) and Major Depressive Disorder (MDD). Front Pharmacol 2019;10:528. [PMID: 31178723 DOI: 10.3389/fphar.2019.00528] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
115 Shinoda Y, Haga Y, Akagawa K, Fukunaga K. Wildtype σ1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity. J Biol Chem 2020;295:17573-87. [PMID: 33453999 DOI: 10.1074/jbc.RA120.015012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Bruna J, Videla S, Argyriou AA, Velasco R, Villoria J, Santos C, Nadal C, Cavaletti G, Alberti P, Briani C, Kalofonos HP, Cortinovis D, Sust M, Vaqué A, Klein T, Plata-Salamán C. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial. Neurotherapeutics 2018;15:178-89. [PMID: 28924870 DOI: 10.1007/s13311-017-0572-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 15.3] [Reference Citation Analysis]
117 Yang H, Shen H, Li J, Guo LW. SIGMAR1/Sigma-1 receptor ablation impairs autophagosome clearance. Autophagy 2019;15:1539-57. [PMID: 30871407 DOI: 10.1080/15548627.2019.1586248] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
118 Váczi S, Barna L, Harazin A, Mészáros M, Porkoláb G, Zvara Á, Ónody R, Földesi I, Veszelka S, Penke B, Fülöp L, Deli MA, Mezei Z. S1R agonist modulates rat platelet eicosanoid synthesis and aggregation. Platelets 2021;:1-10. [PMID: 34697991 DOI: 10.1080/09537104.2021.1981843] [Reference Citation Analysis]
119 Aguinaga D, Medrano M, Cordomí A, Jiménez-rosés M, Angelats E, Casanovas M, Vega-quiroga I, Canela EI, Petrovic M, Gysling K, Pardo L, Franco R, Navarro G. Cocaine Blocks Effects of Hunger Hormone, Ghrelin, Via Interaction with Neuronal Sigma-1 Receptors. Mol Neurobiol 2019;56:1196-210. [DOI: 10.1007/s12035-018-1140-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
120 Abate C, Niso M, Abatematteo FS, Contino M, Colabufo NA, Berardi F. PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti-SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships. Front Pharmacol 2020;11:589810. [PMID: 33364961 DOI: 10.3389/fphar.2020.589810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
121 Stracina T, Novakova M. Cardiac sigma receptors - an update. Physiol Res 2018;67:S561-76. [PMID: 30607964 DOI: 10.33549/physiolres.934052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
122 Gatto EM, Rojas NG, Persi G, Etcheverry JL, Cesarini ME, Perandones C. Huntington disease: Advances in the understanding of its mechanisms. Clin Park Relat Disord 2020;3:100056. [PMID: 34316639 DOI: 10.1016/j.prdoa.2020.100056] [Reference Citation Analysis]
123 Abramova EV, Voronin MV, Seredenin SB. Analysis of Sigma-1 Receptor Binding Ability Under Emotional Stress and Upon Administration of the Anxiolytic Afobazole. Pharm Chem J 2019;53:673-7. [DOI: 10.1007/s11094-019-02060-6] [Reference Citation Analysis]
124 Váczi S, Barna L, Laczi K, Tömösi F, Rákhely G, Penke B, Fülöp L, Bogár F, Janáky T, Deli MA, Mezei Z. Effects of sub-chronic, in vivo administration of sigma non-opioid intracellular receptor 1 ligands on platelet and aortic arachidonate cascade in rats. Eur J Pharmacol 2022;:174983. [PMID: 35487254 DOI: 10.1016/j.ejphar.2022.174983] [Reference Citation Analysis]
125 Collina S, Rui M, Stotani S, Bignardi E, Rossi D, Curti D, Giordanetto F, Malacrida A, Scuteri A, Cavaletti G. Are sigma receptor modulators a weapon against multiple sclerosis disease? Future Medicinal Chemistry 2017;9:2029-51. [DOI: 10.4155/fmc-2017-0122] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
126 Tejada MA, Montilla-García A, Cronin SJ, Cikes D, Sánchez-Fernández C, González-Cano R, Ruiz-Cantero MC, Penninger JM, Vela JM, Baeyens JM, Cobos EJ. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice. Proc Natl Acad Sci U S A 2017;114:8396-401. [PMID: 28716934 DOI: 10.1073/pnas.1620068114] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
127 Zhao J, Gonsalvez GB, Mysona BA, Smith SB, Bollinger KE. Sigma 1 Receptor Contributes to Astrocyte-Mediated Retinal Ganglion Cell Protection. Invest Ophthalmol Vis Sci 2022;63:1. [PMID: 35103752 DOI: 10.1167/iovs.63.2.1] [Reference Citation Analysis]
128 Niso M, Kopecka J, Abatematteo FS, Berardi F, Riganti C, Abate C. Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models. Cell Oncol (Dordr) 2021. [PMID: 34586588 DOI: 10.1007/s13402-021-00638-5] [Reference Citation Analysis]
129 Jia H, Zhang Y, Huang Y. Imaging sigma receptors in the brain: New opportunities for diagnosis of Alzheimer's disease and therapeutic development. Neurosci Lett 2019;691:3-10. [PMID: 30040970 DOI: 10.1016/j.neulet.2018.07.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
130 Wang J, Saul A, Cui X, Roon P, Smith SB. Absence of Sigma 1 Receptor Accelerates Photoreceptor Cell Death in a Murine Model of Retinitis Pigmentosa. Invest Ophthalmol Vis Sci 2017;58:4545-58. [PMID: 28877319 DOI: 10.1167/iovs.17-21947] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
131 Kotańska M, Mika K, Sałaciak K, Wheeler L, Sapa J, Kieć-Kononowicz K, Pytka K. Pitolisant protects mice chronically treated with corticosterone from some behavioral but not metabolic changes in corticosterone-induced depression model. Pharmacol Biochem Behav 2020;196:172974. [PMID: 32565240 DOI: 10.1016/j.pbb.2020.172974] [Reference Citation Analysis]
132 Voronin MV, Vakhitova YV, Tsypysheva IP, Tsypyshev DO, Rybina IV, Kurbanov RD, Abramova EV, Seredenin SB. Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole. Int J Mol Sci 2021;22:5455. [PMID: 34064275 DOI: 10.3390/ijms22115455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Zhao J, Mysona BA, Wang J, Gonsalvez GB, Smith SB, Bollinger KE. Sigma 1 receptor regulates ERK activation and promotes survival of optic nerve head astrocytes. PLoS One 2017;12:e0184421. [PMID: 28898265 DOI: 10.1371/journal.pone.0184421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
134 Maurice T, Goguadze N. Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases. Handb Exp Pharmacol 2017;244:81-108. [PMID: 28275911 DOI: 10.1007/164_2017_15] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
135 Lan Y, Bai P, Chen Z, Neelamegam R, Placzek MS, Wang H, Fiedler SA, Yang J, Yuan G, Qu X, Schmidt HR, Song J, Normandin MD, Ran C, Wang C. Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET). Acta Pharm Sin B 2019;9:1204-15. [PMID: 31867166 DOI: 10.1016/j.apsb.2019.07.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
136 Persaud L, De Jesus D, Brannigan O, Richiez-Paredes M, Huaman J, Alvarado G, Riker L, Mendez G, Dejoie J, Sauane M. Mechanism of Action and Applications of Interleukin 24 in Immunotherapy. Int J Mol Sci 2016;17:E869. [PMID: 27271601 DOI: 10.3390/ijms17060869] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
137 Ago Y, Hasebe S, Hiramatsu N, Hashimoto H, Takuma K, Matsuda T. Psychopharmacology of combined activation of the serotonin 1A and σ 1 receptors. European Journal of Pharmacology 2017;809:172-7. [DOI: 10.1016/j.ejphar.2017.05.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
138 Rossino G, Rui M, Linciano P, Rossi D, Boiocchi M, Peviani M, Poggio E, Curti D, Schepmann D, Wünsch B, González-Avendaño M, Vergara-Jaque A, Caballero J, Collina S. Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization. J Med Chem 2021;64:14997-5016. [PMID: 34624193 DOI: 10.1021/acs.jmedchem.1c00886] [Reference Citation Analysis]
139 Benarroch EE. Sigma-1 receptor and amyotrophic lateral sclerosis. Neurology 2018;91:743-7. [PMID: 30242016 DOI: 10.1212/WNL.0000000000006347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
140 Maurice T, Strehaiano M, Duhr F, Chevallier N. Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ1 receptor. Behav Brain Res 2018;339:1-10. [PMID: 29129596 DOI: 10.1016/j.bbr.2017.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
141 Wang YM, Xia CY, Jia HM, He J, Lian WW, Yan Y, Wang WP, Zhang WK, Xu JK. Sigma-1 receptor: A potential target for the development of antidepressants. Neurochem Int 2022;159:105390. [PMID: 35810915 DOI: 10.1016/j.neuint.2022.105390] [Reference Citation Analysis]
142 Georgiadis MO, Karoutzou O, Foscolos AS, Papanastasiou I. Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity. Molecules 2017;22:E1408. [PMID: 28841173 DOI: 10.3390/molecules22091408] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
143 Zhang X, Wu F, Jiao Y, Tang T, Yang L, Lu C, Zhang Y, Zhang Y, Bai Y, Chao J, Teng G, Yao H. An Increase of Sigma-1 Receptor in the Penumbra Neuron after Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases 2017;26:1981-7. [DOI: 10.1016/j.jstrokecerebrovasdis.2017.06.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
144 Lee PT, Liévens JC, Wang SM, Chuang JY, Khalil B, Wu HE, Chang WC, Maurice T, Su TP. Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models. Nat Commun 2020;11:5580. [PMID: 33149115 DOI: 10.1038/s41467-020-19396-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
145 Agha H, McCurdy CR. In vitro and in vivo sigma 1 receptor imaging studies in different disease states. RSC Med Chem 2021;12:154-77. [PMID: 34046607 DOI: 10.1039/d0md00186d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Bravo-Caparrós I, Ruiz-Cantero MC, Perazzoli G, Cronin SJF, Vela JM, Hamed MF, Penninger JM, Baeyens JM, Cobos EJ, Nieto FR. Sigma-1 receptors control neuropathic pain and macrophage infiltration into the dorsal root ganglion after peripheral nerve injury. FASEB J 2020;34:5951-66. [PMID: 32157739 DOI: 10.1096/fj.201901921R] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
147 Castany S, Gris G, Vela JM, Verdú E, Boadas-Vaello P. Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice. Sci Rep 2018;8:3873. [PMID: 29497125 DOI: 10.1038/s41598-018-22217-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
148 Qu J, Li M, Li D, Xin Y, Li J, Lei S, Wu W, Liu X. Stimulation of Sigma-1 Receptor Protects against Cardiac Fibrosis by Alleviating IRE1 Pathway and Autophagy Impairment. Oxid Med Cell Longev 2021;2021:8836818. [PMID: 33488945 DOI: 10.1155/2021/8836818] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
149 Wang J, Zhao J, Cui X, Mysona BA, Navneet S, Saul A, Ahuja M, Lambert N, Gazaryan IG, Thomas B, Bollinger KE, Smith SB. The molecular chaperone sigma 1 receptor mediates rescue of retinal cone photoreceptor cells via modulation of NRF2. Free Radic Biol Med 2019;134:604-16. [PMID: 30743048 DOI: 10.1016/j.freeradbiomed.2019.02.001] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
150 Mocayar Marón FJ, Ferder L, Saraví FD, Manucha W. Hypertension linked to allostatic load: from psychosocial stress to inflammation and mitochondrial dysfunction. Stress 2019;22:169-81. [DOI: 10.1080/10253890.2018.1542683] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
151 Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, Shetty M, Rodriquez M, Alonge T, Ali M, Katz J, Yan L, Febo M, Henry LK, Bruijnzeel AW, Daws L, Khoshbouei H. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nat Commun 2017;8:2228. [PMID: 29263318 DOI: 10.1038/s41467-017-02087-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 9.6] [Reference Citation Analysis]
152 Mannella P, Simoncini T, Caretto M, Genazzani A. Dehydroepiandrosterone and Cardiovascular Disease. Dehydroepiandrosterone. Elsevier; 2018. pp. 333-53. [DOI: 10.1016/bs.vh.2018.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
153 Maurice T. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders. Expert Opin Drug Discov 2021;16:373-89. [PMID: 33070647 DOI: 10.1080/17460441.2021.1838483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
154 Choi SR, Han HJ, Beitz AJ, Lee JH. Intrathecal interleukin-1β decreases sigma-1 receptor expression in spinal astrocytes in a murine model of neuropathic pain. Biomed Pharmacother 2021;144:112272. [PMID: 34607109 DOI: 10.1016/j.biopha.2021.112272] [Reference Citation Analysis]
155 Ostrovskaya RU, Ivanov SV, Voronin MV, Ozerova IV, Zolotov NN, Seredenin SB. Antidiabetic Activity of Afobazole in Wistar Rats. Bull Exp Biol Med 2018;165:649-52. [DOI: 10.1007/s10517-018-4233-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
156 Wu NH, Ye Y, Wan BB, Yu YD, Liu C, Chen QJ. Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases. Mol Neurobiol 2021. [PMID: 34383254 DOI: 10.1007/s12035-021-02524-5] [Reference Citation Analysis]
157 Pontisso I, Combettes L. Role of Sigma-1 Receptor in Calcium Modulation: Possible Involvement in Cancer. Genes (Basel) 2021;12:139. [PMID: 33499031 DOI: 10.3390/genes12020139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
158 Vavers E, Zvejniece B, Stelfa G, Svalbe B, Vilks K, Kupats E, Mezapuke R, Lauberte L, Dambrova M, Zvejniece L. Genetic inactivation of the sigma-1 chaperone protein results in decreased expression of the R2 subunit of the GABA-B receptor and increased susceptibility to seizures. Neurobiol Dis 2021;150:105244. [PMID: 33385516 DOI: 10.1016/j.nbd.2020.105244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Ryskamp DA, Korban S, Zhemkov V, Kraskovskaya N, Bezprozvanny I. Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases. Front Neurosci 2019;13:862. [PMID: 31551669 DOI: 10.3389/fnins.2019.00862] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 14.0] [Reference Citation Analysis]
160 Mavylutov T, Chen X, Guo L, Yang J. APEX2- tagging of Sigma 1-receptor indicates subcellular protein topology with cytosolic N-terminus and ER luminal C-terminus. Protein Cell 2018;9:733-7. [PMID: 28929457 DOI: 10.1007/s13238-017-0468-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
161 Joffre J, Yeh CC, Wong E, Thete M, Xu F, Zlatanova I, Lloyd E, Kobzik L, Legrand M, Hellman J. Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury. J Immunol 2020;204:3339-50. [PMID: 32385136 DOI: 10.4049/jimmunol.2000213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
162 Wang J, Saul A, Smith SB. Activation of Sigma 1 Receptor Extends Survival of Cones and Improves Visual Acuity in a Murine Model of Retinitis Pigmentosa. Invest Ophthalmol Vis Sci 2019;60:4397-407. [PMID: 31639826 DOI: 10.1167/iovs.19-27709] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
163 Cogram P, Deacon RMJ, Klamer D, Rebowe N, Sprouse J, Reyes ST, Missling CU, Kaufmann WE. Brain cell signaling abnormalities are detected in blood in a murine model of Fragile X syndrome and corrected by Sigma-1 receptor agonist Blarcamesine. Am J Med Genet A 2022. [PMID: 35661397 DOI: 10.1002/ajmg.a.62853] [Reference Citation Analysis]
164 Smith SB, Wang J, Cui X, Mysona BA, Zhao J, Bollinger KE. Sigma 1 receptor: A novel therapeutic target in retinal disease. Prog Retin Eye Res 2018;67:130-49. [PMID: 30075336 DOI: 10.1016/j.preteyeres.2018.07.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
165 Penke B, Fulop L, Szucs M, Frecska E. The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases. Curr Neuropharmacol 2018;16:97-116. [PMID: 28554311 DOI: 10.2174/1570159X15666170529104323] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
166 Meng F, Xiao Y, Ji Y, Sun Z, Zhou X. An open-like conformation of the sigma-1 receptor reveals its ligand entry pathway. Nat Commun 2022;13:1267. [PMID: 35273182 DOI: 10.1038/s41467-022-28946-w] [Reference Citation Analysis]
167 Ye J, Wang L, Deuther-Conrad W, Chen Y, Zhang X, Zhang J, Huang Y, Brust P, Jia H. 18 F-Labeled benzylpiperazine derivatives as highly selective ligands for imaging σ1 receptor with positron emission tomography. J Labelled Comp Radiopharm 2019;62:425-37. [PMID: 30991462 DOI: 10.1002/jlcr.3738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
168 Murakami H, Shiraishi T, Umehara T, Omoto S, Iguchi Y. Recent Advances in Drug Therapy for Parkinson's Disease. Intern Med 2022. [PMID: 35110492 DOI: 10.2169/internalmedicine.8940-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Grimm N, Lee JT. Selective Xi reactivation and alternative methods to restore MECP2 function in Rett syndrome. Trends in Genetics 2022. [DOI: 10.1016/j.tig.2022.01.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Delint-Ramirez I, Garcia-Oscos F, Segev A, Kourrich S. Cocaine engages a non-canonical, dopamine-independent, mechanism that controls neuronal excitability in the nucleus accumbens. Mol Psychiatry 2020;25:680-91. [PMID: 29880884 DOI: 10.1038/s41380-018-0092-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
171 Wang T, Zhang Y, Zhang X, Chen L, Zheng M, Zhang J, Brust P, Deuther-conrad W, Huang Y, Jia H. Synthesis and characterization of the two enantiomers of a chiral sigma-1 receptor radioligand: (S)-(+)- and (R)-(-)-[18F]FBFP. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.03.099] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Lau DHW, Paillusson S, Hartopp N, Rupawala H, Mórotz GM, Gomez-Suaga P, Greig J, Troakes C, Noble W, Miller CCJ. Disruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer's disease brain. Neurobiol Dis 2020;143:105020. [PMID: 32682953 DOI: 10.1016/j.nbd.2020.105020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
173 Zhang D, Wang F, Li P, Gao Y. Mitochondrial Ca2+ Homeostasis: Emerging Roles and Clinical Significance in Cardiac Remodeling. Int J Mol Sci 2022;23:3025. [PMID: 35328444 DOI: 10.3390/ijms23063025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Bogár F, Fülöp L, Penke B. Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands. Biomolecules 2022;12:363. [DOI: 10.3390/biom12030363] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Brailoiu E, Chakraborty S, Brailoiu GC, Zhao P, Barr JL, Ilies MA, Unterwald EM, Abood ME, Taylor CW. Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP3-Evoked Ca2+ Signals through Sigma-1 Receptors. Cell Rep 2019;26:330-337.e4. [PMID: 30625315 DOI: 10.1016/j.celrep.2018.12.051] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
176 Tian J, He Y, Deuther-conrad W, Fu H, Xie F, Zhang Y, Wang T, Zhang X, Zhang J, Brust P, Huang Y, Jia H. Synthesis and evaluation of new 1-oxa-8-azaspiro[4.5]decane derivatives as candidate radioligands for sigma-1 receptors. Bioorganic & Medicinal Chemistry 2020;28:115560. [DOI: 10.1016/j.bmc.2020.115560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]